The person depicted is a model used for illustrative purposes only.
MENVEO is a solution for intramuscular injection supplied in 2 vials the contents of which must be combined prior to administration1:
After reconstitution, a single dose of MENVEO is 0.5 mL1
Please note that neither component should be given alone.
MENVEO can be reconstituted in 3 steps: PULL, MIX, and SHAKE1
PULL the MenCYW-135 liquid from the vial
MIX the MenCYW-135 liquid with the MenA conjugate
SHAKE the vial upside down until the vaccine is dissolved
Watch the reconstitution video
MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. MENVEO is approved for use in persons 2 months through 55 years of age. MENVEO does not prevent N. meningitidis serogroup B infections.